---
company: GMR Solutions Inc.
ticker: GMRS
form: 8-K
filed: 2026-08-12
accession: 0001104659-26-095027
source: https://www.sec.gov/Archives/edgar/data/1898718/000110465926095027/
---

# GMR Solutions (GMRS) earnings release, August 12, 2026

GMR Solutions Inc. (GMRS) · Form 8-K, Item 2.02 · Filed 2026-08-12 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1898718/000110465926095027/)

​

​

GMR Solutions Inc. Reports Financial Results for the Three and Six Months Ended June 30, 2026 and Reaffirms Full Year 2026 Guidance

LEWISVILLE, Texas (August 12, 2026) — GMR Solutions Inc. (“GMR” or the “Company”) (NYSE: GMRS), the nation’s largest provider of emergency medical services (“EMS”), today announced financial results for the three and six months ended June 30, 2026, and updated its full year 2026 financial guidance.

“We are pleased with our second quarter results, which reflect operational execution and continued momentum across our business,” said Nick Loporcaro, Chairman and Chief Executive Officer at GMR. “We expanded our core emergency services, secured new business wins, and continued advancing innovative solutions such as 911 Nurse Navigation, while maintaining our focus on delivering exceptional patient care. As the nation’s only integrated air and ground medical services platform, we believe we are uniquely positioned to capitalize on growth opportunities, deliver clinical excellence, and drive long-term value creation through disciplined execution.”

“We delivered strong operational and financial performance during the second quarter, reflecting continued demand for our services and disciplined execution across the enterprise,” said Brian Tierney, Chief Financial Officer. “The prior-year period benefited from favorable revenue estimate developments driven by unusually strong collections on No Surprises Act claims related to prior years of service, resulting in a $74.3 million year-over-year difference in changes in revenue estimates. Despite this comparison dynamic, the underlying performance of our business remains strong, and we are reaffirming our full-year guidance, based on our results to date and outlook for the remainder of the year.”

Second Quarter 2026 Financial Highlights

​

​

​

​

​¹

​

​

Key Financials

​

​

​

Business Metrics

​

​

​

​

​

​

​

​

​²

​

​

Full Year 2026 Financial Guidance

​

GMR is reaffirming the following guidance for the full year 2026:

​

​

​

Webcast and Conference Call Details

​

The Company will host a conference call tomorrow, August 13, 2026, at 8:30 a.m. Eastern Time. Investors can access the live call by joining the following link https://events.q4inc.com/attendee/831059655.

​

An archived webcast of the event will be available on the “Events & Presentations” section of the GMR website at https://investors.globalmedicalresponse.com/. The Company has posted supplemental information on the results that it will reference during the conference call. The supplemental information can be found under the “Financials” tab on the Company’s investor relations page. Following the live event, replays will be available via webcast for one year at https://investors.globalmedicalresponse.com/.

​

About Global Medical Response

​

GMR is the nation’s largest provider of EMS, delivering EMS and other essential out-of-hospital care in rural and urban communities that represent approximately 60% of the U.S. population. As the only national, fully integrated, air and ground EMS provider, GMR operates in approximately 1,400 counties across the country. A recognized innovator, GMR develops new solutions to meet evolving industry needs and expand access to high-quality care. With roughly 34,000 team members, GMR supports roughly 5.5 million patient encounters annually and performs a critical care intervention every 88 seconds. Its family of solutions includes ambulance EMS provider American Medical Response, as well as multiple air EMS organizations including Air Evac Lifeteam, REACH Air Medical Services, Guardian Flight, Med-Trans Corporation, and AirMed International.

​

We may use our website (www.globalmedicalresponse.com), Facebook page (www.facebook.com/GlobalMedicalResponse), X (Twitter) (www.x.com/GMR_Social), LinkedIn (www.linkedin.com/company/Global-Medical-Response), and Instagram (www.instagram.com/Global_Medical_Response), accounts as channels of distribution of company information. The information we post through these channels may be deemed material. Accordingly, investors should monitor these channels, in addition to following our press releases, Securities and Exchange Commission (“SEC”) filings and public conference calls and webcasts. In addition, you may automatically receive email alerts and other information about the Company when you enroll your email address by visiting the “Investor Email Alerts” section of our website at https://investors.globalmedicalresponse.com/resources/investor-email-alerts/default.aspx. The contents of our website, any alerts and social media channels are not, however, a part of this press release.

​

Forward-Looking Statements

​

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect our current views with respect to, among other things, our operations and financial performance. Forward-looking statements include all statements that are not historical facts, including statements related to our ability to capitalize on growth opportunities, drive long-term value creation and expand our services and statements regarding growth opportunities, delivery of services and our financial guidance. These forward-looking statements may relate to matters which include, but are not limited to, industries, business strategy, goals and expectations concerning our market position, future operations, margins, profitability, capital expenditures, liquidity and capital resources and other financial and operating information. In some cases, you can identify these forward-looking statements by the use of words such as “anticipate,” “assume,” “believe,” “can,” “continue,” “could,”³

​

“estimate,” “expect,” “foreseeable,” “future,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “will,” “would,” the negative version of these words, or similar terms and phrases....forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The forward-looking statements are subject to various risks, uncertainties, assumptions or changes in circumstances that are difficult to predict or quantify. Our expectations, beliefs and projections are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that management’s expectations, beliefs, and projections will result or be achieved. Actual results may differ materially from these expectations due to changes in global, regional or local economic, business, competitive, market, regulatory and other factors, many of which are beyond our control. We believe that these factors include but are not limited to the following:⁴

​

These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included herein and in our filings with the SEC, including the information under the captions “Risk Factors” in GMR’s final prospectus (the “IPO Prospectus”) in connection with our initial public offering (the “IPO”), filed with the SEC and dated May 12, 2026, as well as GMR’s subsequent other filings with the SEC from time to time. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, our actual results may vary in material respects from those projected in these forward-looking statements.

​

Any forward-looking statement made by us herein speaks only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included herein. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, investments, or other strategic transactions we may make. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws. For additional information on these and other factors that could cause GMR’s actual results to differ materially from expected results, please see our filings with the SEC, which are accessible on the SEC’s website at www.sec.gov and on the “Investor Relations” tab of our website.

Non-GAAP Financial Measures

This press release contains “non-GAAP financial measures,” which are financial measures that either exclude or include amounts that are not excluded or included in the most directly comparable measures calculated and presented in accordance with GAAP. Specifically, we make use of the non-GAAP financial measures “EBITDA” and “Adjusted EBITDA.”

We provide non-GAAP financial information to enhance the understanding of our GAAP financial information and it should be considered by the reader in addition to, but not instead of, the financial statements prepared in accordance with GAAP. Each non-GAAP financial measure is presented along with the corresponding GAAP measure so as not to imply that more emphasis should be placed on the non-GAAP measure. We believe that providing these non-GAAP measures in addition to the GAAP measures allows management, investors and other users of our financial information to more fully and accurately assess performance. The non-GAAP financial information presented may be determined or calculated differently by other companies and may not be directly comparable to that of other companies.

​

We define EBITDA as net income (loss) before interest expense, net, income tax provision (benefit), and depreciation and amortization. We define Adjusted EBITDA as EBITDA, as further adjusted to exclude management fees, non-cash stock-based compensation, professional fees and other expenses for non-recurring matters, debt financing fees paid to (received from) third parties and certain other items that we do not consider indicative of our ongoing operating performance.

​

Management uses EBITDA and Adjusted EBITDA to supplement GAAP measures of performance in the evaluation of the effectiveness of our business strategies, to make budgeting decisions, to establish and award discretionary annual incentive compensation, to report compliance with certain covenants in our debt agreements and to compare our performance against that of peer companies using similar measures. Moreover, we present EBITDA and Adjusted EBITDA because we believe that investors consider them to be important supplemental measures of our performance and believe these measures are frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry.

​⁵

​... (truncated)ined.

​

GMR Contacts:

Media Contact:

Kirsten Gurmendi

Public Relations Director, GMR Solutions Inc. media@gmr.net

877.418.2980

Investor Contact:

Krister Sorensen

Vice President, Investor Relations, GMR Solutions Inc.

Investor.relations@gmr.net

​⁶

​

GMR Solutions Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

June 30, 2026 and December 31, 2025

(Amounts in thousands, except share and par value amounts)

​

​

​⁷

​

GMR Solutions Inc. and Subsidiaries

Consolidated Statements of Operations

For the three and six months ended June 30, 2026 and 2025

(

Amounts in thousands, except share and per share amounts, unaudited)

​

​

​⁸

​

GMR Solutions Inc. and Subsidiaries

Consolidated Statements of Cash Flows

For the six months ended June 30, 2026 and 2025

(Amounts in thousands, unaudited)

​⁹

​

GMR Solutions Inc. and Subsidiaries

Reconciliation of EBITDA and Adjusted EBITDA

For the three and six months ended June 30, 2026 and 2025

(Amounts in thousands, unaudited)

The following table reconciles net income to EBITDA and Adjusted EBITDA:

​ nm – Not meaningful

​

​

​

​

​¹⁰

​

​

​

​

​

​

​

​

​

​¹¹

​

## Financial statements

### Income Statement (Three Months Ended — Key Financials (in thousands))

| | Three Months Ended – June 30, – 2026 – (Unaudited) | Three Months Ended – June 30, – 2025 – (Unaudited) | % | Six Months Ended – June 30, – 2026 – (Unaudited) | Six Months Ended – June 30, – 2025 – (Unaudited) | % |
|---|---:|---:|---:|---:|---:|---:|
| Net revenue | 1,490,286 | 1,442,011 | 3.3% | 2,947,862 | 2,809,418 | 4.9% |
| Net income | -28,278 | 80,761 | -135.0% | 78,058 | 118,785 | -34.3% |
| Adjusted EBITDA(1) | 284,536 | 322,574 | -11.8% | 589,588 | 600,635 | -1.8% |

### Income Statement (Range for the year ending — GMR is reaffirming the following guidance for the full year 2026: (in millions))

| | Range for the year ending – December 31, 2026 – Low | Range for the year ending – December 31, 2026 – High |
|---|---:|---:|
| Net revenue | 5,890 | 6,180 |
| Adjusted EBITDA(2) | 1,135 | 1,195 |
| Cash used for net capital expenditures and aircraft financing as a percent of net revenue | 5.1% | 5.3% |

### Income Statement (Three Months Ended — ))

| | Three Months Ended – June 30, – 2026 | Three Months Ended – June 30, – 2025 | Six Months Ended – June 30, – 2026 | Six Months Ended – June 30, – 2025 |
|---|---:|---:|---:|---:|
| Net revenue | 1,490,286 | 1,442,011 | 2,947,862 | 2,809,418 |
| Operating expenses: | Employee wages, benefits and taxes | 924,522 | 742,617 | 1,694,528 | 1,477,375 |
| Operating expenses: | Maintenance, fuel and other direct expenses | 136,417 | 112,617 | 255,037 | 224,428 |
| Operating expenses: | Insurance expense | 50,877 | 51,301 | 93,856 | 84,953 |
| Operating expenses: | Other operating expenses | 231,900 | 220,908 | 459,994 | 436,714 |
| Operating expenses: | Depreciation and amortization | 76,956 | 72,507 | 152,323 | 147,634 |
| Operating expenses: | Impairment of assets held for sale and other investments |  |  |  | 14,100 |
| Operating expenses: | Acquisition, integration and other charges | 12,925 | 1,055 | 16,537 | 5,356 |
| Operating expenses: | Total operating expenses | 1,433,597 | 1,201,005 | 2,672,275 | 2,390,560 |
| Operating expenses: | Operating income | 56,689 | 241,006 | 275,587 | 418,858 |
| Operating expenses: | Interest expense, net | 76,848 | 108,516 | 160,022 | 222,201 |
| Operating expenses: | Equity in (earnings) losses of unconsolidated affiliates | -436 | -272 | -899 | -2,574 |
| Operating expenses: | Other (income) loss, net | -425 | 10,468 | -6,769 | 9,546 |
| Operating expenses: | Net income (loss) before income taxes | -19,298 | 122,294 | 123,233 | 189,685 |
| Operating expenses: | Income tax (benefit) expense | 8,980 | 41,533 | 45,175 | 70,900 |
| Operating expenses: | Net income (loss) | -28,278 | 80,761 | 78,058 | 118,785 |
| Net income (loss) available to common stockholders per share: | Basic | -1.84 | 0.87 | -1.35 | 0.84 |
| Net income (loss) available to common stockholders per share: | Diluted | -1.84 | 0.27 | -1.35 | 0.26 |
| Weighted-average common shares outstanding: | Basic | 62,678,438 | 45,554,662 | 54,304,118 | 45,552,980 |
| Weighted-average common shares outstanding: | Diluted | 62,678,438 | 148,265,105 | 54,304,118 | 148,084,828 |
| Comprehensive income (loss): | Net income (loss) | -28,278 | 80,761 | 78,058 | 118,785 |
| Other comprehensive income (loss) | Unrealized holding gains (losses) on investments | 837 | 371 | 313 | 839 |
| Other comprehensive income (loss) | Deferred income tax benefit (expense), net | -186 | -82 | -70 | -186 |
| Other comprehensive income (loss) | Total other comprehensive income (loss), net of income tax | 651 | 289 | 243 | 653 |
| Other comprehensive income (loss) | Comprehensive income (loss) | -27,627 | 81,050 | 78,301 | 119,438 |

### Income Statement (Three Months Ended — The following table reconciles net income to EBITDA and Adjusted EBITDA:)

| | Three Months Ended – June 30, – 2026 | Three Months Ended – June 30, – 2025 | 2026 v. – 2025 Change | Six Months Ended – June 30, – 2026 | Six Months Ended – June 30, – 2025 | 2026 v. – 2025 Change |
|---|---:|---:|---:|---:|---:|---:|
| Net income (loss) | -28,278 | 80,761 | -135 | 78,058 | 118,785 | -34.3 |
| Interest expense, net | 76,848 | 108,516 | -29.2 | 160,022 | 222,201 | -28 |
| Income tax provision (benefit) | 8,980 | 41,533 | -78.4 | 45,175 | 70,900 | -36.3 |
| Depreciation and amortization | 76,956 | 72,507 | 6.1 | 152,323 | 147,634 | 3.2 |
| EBITDA | 134,506 | 303,317 | -55.7 | 435,578 | 559,520 | -22.2 |
| Management fees(1) | 1,744 | 2,705 | -35.5 | 4,721 | 5,410 | -12.7 |
| Stock-based compensation(2) | 132,602 | 2,987 | 4,339.3 | 132,511 | 5,592 | 2,269.7 |
| Professional fees and other expenses for non-recurring matters(3) | 16,234 | 2,821 | 475.5 | 23,145 | 7,375 | 213.8 |
| Debt refinancing fees paid to (received from) third parties(4) | 239 | -10 | -2,490 | 559 | 373 | 49.9 |
| Impairment of assets held for sale and other investments(5) |  |  | nm |  | 14,100 | nm |
| (Gain) loss on divestiture of businesses(6) |  | 5,259 | nm |  | 3,837 | nm |
| Realized and unrealized (gain) loss, net(7) | -353 | 5,767 | -106.1 | -6,027 | 7,002 | -186.1 |
| Equity method investment (income) loss(8) | -436 | -272 | 60.3 | -899 | -2,574 | -65.1 |
| Adjusted EBITDA | 284,536 | 322,574 | -11.8 | 589,588 | 600,635 | -1.8 |

### Balance Sheet (December 31, — (Amounts in thousands, except share and par value amounts))

| | June 30, – 2026 – (unaudited) | December 31, – 2025 |
|---|---:|---:|
| Current assets: | Cash and cash equivalents | 420,001 | 609,349 |
| Current assets: | Insurance collateral | 76,755 | 78,608 |
| Current assets: | Accounts receivable, net | 1,166,369 | 1,094,814 |
| Current assets: | Spare parts, medical supplies and fuel | 127,819 | 115,725 |
| Current assets: | Prepaid expenses | 84,663 | 105,014 |
| Current assets: | Other current assets | 147,372 | 128,571 |
| Current assets: | Total current assets | 2,022,979 | 2,132,081 |
| Current assets: | Property and equipment, net of accumulated depreciation of $1,303,633 and $1,223,603 at June 30, 2026 and December 31, 2025, respectively | 1,411,068 | 1,361,278 |
| Current assets: | Operating right-of-use assets | 216,206 | 203,258 |
| Current assets: | Finance right-of-use assets | 84,239 | 85,030 |
| Current assets: | Intangible assets, net | 1,171,914 | 1,204,237 |
| Current assets: | Goodwill | 2,180,581 | 2,180,581 |

### Cash Flow (Six Months Ended — (Amounts in thousands, unaudited))

| | Six Months Ended – June 30, – 2026 | Six Months Ended – June 30, – 2025 |
|---|---:|---:|
| Cash flows from operating activities: | Net income (loss) | 78,058 | 118,785 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities | Depreciation and amortization | 152,323 | 147,634 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities | Amortization of deferred financing costs and debt discount | 4,777 | 8,188 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities | Paid-in-kind interest on long-term debt |  | 15,579 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities | Impairment of assets held for sale and other investments |  | 14,100 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities | (Gain) loss on divestiture of businesses |  | 3,837 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities | Stock-based compensation expense | 132,511 | 1,422 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities | Liability classified stock awards |  | 4,169 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities | Loss (gain) on disposal of property and equipment | 1,855 | 5,290 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities | Unrealized loss (gain) on marketable equity securities | 873 | 784 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities | Deferred income taxes | -8 | -4 |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities | Other, net | -7,800 | 3,645 |
| Changes in assets and liabilities, net of effects of acquisitions | Accounts receivable, net | -71,555 | -54,923 |
| Changes in assets and liabilities, net of effects of acquisitions | Accounts payable | 4,007 | 8,923 |
| Changes in assets and liabilities, net of effects of acquisitions | Accrued wages, benefits and taxes | -62,806 | -20,553 |
| Changes in assets and liabilities, net of effects of acquisitions | Accrued interest | -51,007 | 27,138 |
| Changes in assets and liabilities, net of effects of acquisitions | Accrued liabilities | 43,952 | -60,027 |
| Changes in assets and liabilities, net of effects of acquisitions | Other assets and liabilities, net | -7,854 | -5,314 |
| Changes in assets and liabilities, net of effects of acquisitions | Net cash provided by (used in) operating activities | 217,326 | 218,673 |
| Cash flows from investing activities: | Proceeds from divestiture of businesses |  | 2,819 |
| Cash flows from investing activities: | Proceeds from asset disposals related to sales and insurance recoveries | 1,323 | 633 |
| Cash flows from investing activities: | Purchases of property and equipment | -137,989 | -111,600 |
| Cash flows from investing activities: | Net change in investments held as insurance collateral | -572 | -1,857 |
| Cash flows from investing activities: | Purchases of marketable securities | -64,563 | -20,300 |
| Cash flows from investing activities: | Sales and maturities of marketable securities | 60,678 | 25,956 |
| Cash flows from investing activities: | Other investing activities, net | 14,675 | -3,347 |
| Cash flows from investing activities: | Net cash provided by (used in) investing activities | -126,448 | -107,696 |
| Cash flows from financing activities: | Payments on finance lease obligations | -6,401 | -7,473 |
| Cash flows from financing activities: | Principal payments on long-term debt | -750,351 | -76,100 |
| Cash flows from financing activities: | Proceeds from issuance of long-term debt | 73,037 | 77,026 |
| Cash flows from financing activities: | Issuance of common stock, net | 446,904 |  |
| Cash flows from financing activities: | Repurchase of common stock |  | -86 |
